ÇѸ²´ëÇб³µ¿Åº¼º½Éº´¿ø

ÀÇ·áÁø »çÁø
ÀüÀ¯ÈÆ ±³¼ö
Áø·á°ú ¼Ò¾Æû¼Ò³â°ú HOME

Àü¹®Áø·áºÐ¾ß

¼Ò¾Æ¾Ë·¹¸£±âÈ£Èí±â, ¾ÆÅäÇÇÇǺο°, ºñ¿°, õ½Ä, ½ÄÇ°¾Ë·¹¸£±â, µÎµå·¯±â

ÀüÈ­ ¿¹¾à 1522-2500

(ÁÖ°£) Áø·á½Ã°£Ç¥ (2024-09-30 ~ 2024-10-05)

Áø·á½Ã°£Ç¥
Áø·á½Ã°£ ¿ù È­ ¼ö ¸ñ ±Ý Åä
¿ÀÀü ¿Ü·¡Áø·á¿Ü·¡Áø·á¿Ü·¡Áø·á
¿ÀÈÄ ¿Ü·¡Áø·á

ÇзÂ

ÇзÂ

2002¼øõÇâ´ëÇб³ ÀÇ°ú´ëÇÐ Á¹¾÷

2007¼øõÇâ´ëÇб³ ÀϹݴëÇпø ÀÇÇÐ ¼®»ç

2009¼øõÇâ´ëÇб³ ÀϹݴëÇпø ÀÇÇÐ ¹Ú»ç

°æ·Â

°æ·Â

2002 ~ 2006¼øõÇâ´ëÇб³º´¿ø ¼ö·Ã/Àü°øÀÇ ¼ö·á

2007 ~ 2008¼øõÇâ´ëÇб³º´¿ø ¼Ò¾Æû¼Ò³â°ú ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±â¼¾ÅÍ ÀüÀÓÀÇ

2008 ~ 2009¼øõÇâ´ëÇб³º´¿ø ¼Ò¾Æû¼Ò³â°ú ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±â ¼¼ºÎÀü¹®ÀÇ

2009 ~ 2010¼­¿ïÀû½ÊÀÚº´¿ø ¼Ò¾Æ°ú °úÀå

ÇѸ²´ëÇб³µ¿Åº¼º½Éº´¿ø ¼Ò¾Æû¼Ò³â°ú ºÎ±³¼ö

ÇÐȸȰµ¿

ÇÐȸȰµ¿

2015 ~ ´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ ÇмúÀ§¿øȸ À§¿ø

2013 ~ 2015´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ ¹ýÁ¦À§¿øȸ À§¿ø

2013 ~ ´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ ½ÄÇ°¾Ë·¹¸£±â ¾ÆÅäÇÇÇǺο° ¿¬±¸È¸(FAAD) À§¿ø

2011 ~ 2012´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ °í½ÃÀ§¿øȸ ¼±ÅÃÀ§¿ø

2015 ~ ´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ ±³°ú¼­ÆíÂùÀ§¿øȸ À§¿ø

2015 ~ ´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ Àü»êÁ¤º¸À§¿øȸ °£»ç

2016 ~ ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ È«º¸À§¿øȸ À§¿ø

¼ö»óÀÌ·Â

¼ö»óÀÌ·Â

2007´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ MSD ¿¬±¸Çмú»ó

2007´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ µå¸²Æĸ¶ ¿¬±¸Çмú»ó

2008´ëÇÑ ¼Ò¾Æ°úÇÐȸ MSD Çмú»ó

2008´ëÇѼҾưúÇÐȸ GSK ¿ì¼öÃÊ·Ï»ó

2010¾Æ½Ã¾Æ ÅÂÆò¾ç ¾Ë·¹¸£±â õ½Ä ÀÓ»ó ¸é¿ªÇÐȸ(APCAACI) ¿ì¼ö³í¹®»ó

2011ÀϺ»¼Ò¾Æ¾Ë·¹¸£±â ¸é¿ªÇÐȸ(JSPACI) ¿ì¼ö³í¹®»ó

2015ÀϺ»¼Ò¾Æ¾Ë·¹¸£±â ¸é¿ªÇÐȸ(JSPACI) ¿ì¼ö³í¹®»ó

2017´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ »ï¾ÆÇмú»ó ÃÖ¿ì¼ö³í¹®»ó

2018´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ ¾Ë·¯°íÆĸ¶ Çмú»ó

³í¹®/Àú¼­

³í¹®/Àú¼­
´ëÇ¥ ³í¹®
1. Pollen-food allergy syndrome in children. Clin Exp Pediatr. 2020 Dec;63(12):463-468.

2. The KAAACI/KDA Evidence-Based Practice Guidelines for Chronic Spontaneous Urticaria in Korean Adults and Children: Part 1. Definition, Methodology and First-line Management. Allergy Asthma Immunol Res. 2020 Jul;12(4):563-578.

3. The KAAACI/KDA Evidence-Based Practice Guidelines for Chronic Spontaneous Urticaria in Korean Adults and Children: Part 2. Management of H1-Antihistamine-Refractory Chronic Urticaria. Allergy Asthma Immunol Res. 2020 Sep;12(5):750-770.

4. Metabolic syndrome and lung function in Korean children and adolescents: A cross-sectional study. Sci Rep 9, 15646 (2019). https://doi.org/10.1038/s41598-019-51968-2

5. Effect of Vacuuming Mattresses on Allergic Rhinitis Symptoms in Children. Allergy Asthma Immunol Res. 2019 Sep;11(5):e57

6. Infantile Anaphylaxis in Korea: a Multicenter Retrospective Case Study. J Korean Med Sci. 2019 Apr 8;34(13):e106

7. The current status and issue of food allergen labeling in Korea. Allergy Asthma Respir Dis 7(2):67-72, April 2019

8. Clinical Characteristics of Oral Allergy Syndrome in Children with Atopic Dermatitis and Birch Sensitization: a Single Center Study. J Korean Med Sci. 2019 Jan 14;34(2):e11

9. KAAACI Evidence-Based Clinical Practice Guidelines for Chronic Cough in Adults and Children in Korea. Allergy Asthma Immunol Res. 2018 Nov;10(6):591-613

10. Epidemiology of food allergy in Korean children. Allergy Asthma Respir Dis 6(1):4-13, January 2018

11. Age-Based Causes and Clinical Characteristics of Immediate-Type Food Allergy in Korean Children. Allergy Asthma Immunol Res. 2017 Sep;9(5):423-430.

12. Treatment of community-acquired pneumonia in Korean children. Allergy Asthma & Respiratory Diseases 2017 Jul;5(4):177-184.

13. A multicenter study on anaphylaxis caused by peanut, tree nuts, and seeds in children and adolescents. Allergy. 2017 Mar;72(3):507-510.

14. A Multicenter Retrospective Case Study of Anaphylaxis Triggers by Age in Korean Children. Allergy Asthma
Immunol Res. 2016 Nov;8(6):535-40.

15. A Double-Blind, Randomized, Crossover Study to Compare the Effectiveness of Montelukast on Atopic Dermatitis in Korean Children. Allergy Asthma Immunol Res. 2016 Jul;8(4):305-11.

16. Does the different amount of short-acting bronchodilator drugs have different effects on small airway response in bronchodilator test? Allergy Asthma Respir Dis 4(4):284-289, July 2016

17. Agreement between the skin prick test and specific serum IgE for egg white and cow's milk allergens in young infant with atopic dermatitis. Allergol Int. 2014 ;63(2):235-42.

18. The Clinical Usefulness of IgE Antibodies Against Egg White and Its Components in Korean Children. Allergy Asthma Immunol Res. 2013;5(3):138-42.

19. ¼Ò¾Æ ¾Ë·¹¸£±âºñ¿°ÀÇ °æÁ¦Àû ºÎ´ã Æò°¡¸¦ À§ÇÑ ´Ù±â°ü Á¶»ç. ¼Ò¾Æ¾Ë·¹¸£±â ¹× È£Èí±âÇÐȸÁö 2012;22:138-46

20. ½ÄÇ° °æ±¸À¯¹ß½ÃÇè °¡À̵å¶óÀÎ. ¼Ò¾Æ¾Ë·¹¸£±â ¹× È£Èí±âÇÐȸÁö 2012;22:3-20

21. The efficacy of the upright position on gastro-esophageal reflux and reflux-related respiratory symptoms in infants with chronic respiratory symptoms. Allergy Asthma Immunol Res 2012;4:17-23

22. Identification of major rice allergen and their clinical significance in children. Korean J Pediatr 2011;54:414-21

23. Evaluation of patient's subjective severity using various scoring system in Korean children with atopic dermatitis. Asian Pac J Allergy Immunol 2010;28:130-5

24. Pleural effusion and disseminated intravascular coagulopathy: the rarely reported complications of kawasaki disease. Clin Pediatr (Phila) 2010;49:598-600

25. ¼Ò¾Æ õ½Ä ȯÀÚ¿¡¼­ °ÔÀÓÀ» ÅëÇÑ Ãµ½Ä ±³À°¹ýÀÇ À¯¿ë¼º. õ½Ä ¹× ¾Ë·¹¸£±â 2009;29:262-8

26. Çѱ¹ ¼Ò¾Æ ¾Ë·¹¸£±âºñ¿° ȯÀÚÀÇ »îÀÇ Áú¿¡ ´ëÇÑ ¼³¹® °³¹ß ¹× À¯¿ë¼º Æò°¡¸¦ À§ÇÑ ¿¬±¸. õ½Ä ¹× ¾Ë·¹¸£±â 2009;29:242-8

27. ¼Ò¾Æ õ½Äȯ¾Æ¿¡¼­ ÈíÀÔ¿ë fluticasone ¹× tulobuterolÀÇ º´ÇÕÄ¡·á¿Í µÎ¹è ¿ë·® ÈíÀÔ¿ë fluticasone Ä¡·áÀÇ È¿°ú ¹× ¾ÈÀü¼º ºñ±³¿¡ ´ëÇÑ ´Ù±â°ü ¿¬±¸. ¼Ò¾Æ¾Ë·¹¸£±â ¹× È£Èí±âÇÐȸÁö 2009;19:125-36

28. Lung function in Korean adolescent girls: in association with obesity and the menstrual cycle. J Korean Med Sci 2009;24:20-5

29. Elevation of the index of left ventricular mass during the acute and subacute phase of Kawasaki disease, and its association with indexes of diastolic function. Cardiol Young 2009;19:64-9

30. »çÃá±â ¿©¾Æ¿¡¼­ ºñ¸¸, ¿ù°æÁÖ±â¿Í Æó±â´ÉÀÇ °ü°è. ¼øõÇâ´ëÇб³ ¼®»çÇÐÀ§³í¹® 2007

31. ½Ò Ç׿ø °¨ÀÛÀÇ ÀÓ»óÀû ÀÇÀÇ¿Í ½ÒÀÇ ÁÖÇ׿ø ±Ô¸í¿¡ ´ëÇÑ ¿¬±¸. ¼øõÇâ´ëÇб³ ¹Ú»çÇÐÀ§³í¹® 2008

32. ¼Ò¾Æ ¾ÆÅäÇÇÇǺο°¿¡¼­ ¾ÆÅäÇǼº°ú ºñ¾ÆÅäÇǼºÀÇ ÁßÁõµµ¿Í °Ë»ç¼Ò°ßÀÇ ºñ±³. ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸÁö 2008;18:219-27

33. ¿µ¾Æ±â ¾ÆÅäÇÇÇǺο° ȯÀÚÀÇ Ãµ¸í¹ß»ý À§ÇèÀÎÀÚ¿¡ ´ëÇÑ ¿¬±¸. ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸÁö 2007;17:109-16

34. ¹Ýº¹ÀûÀÎ ¿µ¾Æ õ¸í¿¡¼­ Áö¼Ó¼º õ¸íÀ¸·ÎÀÇ ÁøÇà¿¡ °ü¿©ÇÏ´Â À§Çè ÀÎÀÚ. ¼Ò¾Æ¾Ë·¹¸£±â ¹× È£Èí±âÇÐȸÁö 2006;17:17-26

Àú¼­/Àú¼ú
1. ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐ, Á¦ 2ÆÇ ÁýÇÊÁø

2. ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐ, Á¦ 3ÆÇ ÁýÇÊÁø, ÆíÁýÀ§¿ø

¾ð·Ðº¸µµ

°Ç°­Á¤º¸ µ¿¿µ»ó